Both plasma and urine redox biomarkers can be used to assess systemic antioxidant status in patients with adrenal tumors. Sun et al. developed a computed tomography (CT) -based radiological-clinical ...

Atumelnant is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome. For more information about the Phase 2 TouCAHn study in classic CAH, please visit ...

Overexpression of this receptor or inability to desensitize it is found in adrenal adenomas or hyperplasia associated with glucocorticoid overproduction (Cushing syndrome). These disorders are ...